CLB Earnings & Financial Statements
Core Laboratories N.V.
$9.77
-$0.39(-3.84%)
45
Overall
80
Value
18
Tech
39
Quality
Market Cap
$466.19M
Volume
694.61K
52W Range
$9.63 - $20.36
Target Price
$15.67
CLB earnings and financial statements: Core Laboratories N.V.'s income statement, balance sheet and cash flow statement, annual and quarterly.
CLB Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $526.52M | $523.85M | $509.79M | $489.74M | $470.25M |
| Cost of revenue | $432.24M | $435.48M | - | $410.82M | $386.41M |
| Operating income | $56.47M | $58.56M | $54.64M | $41.52M | $45.26M |
| EBITDA | $71.12M | $73.51M | $70.42M | $58.69M | $63.78M |
| Net income | $29.67M | $31.40M | $36.67M | $19.45M | $19.73M |
| EPS (diluted) | $0.63 | $0.66 | $0.78 | $0.42 | $0.43 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $584.01M | $585.13M | $586.39M | $578.35M | $580.85M |
| Total liabilities | $301.98M | $316.37M | $345.89M | $389.40M | $419.85M |
| Shareholders’ equity | $265.99M | $246.57M | $224.81M | $184.26M | $156.45M |
| Cash and equivalents | $22.70M | $19.16M | $15.12M | $15.43M | $17.70M |
| Long-term debt | $152.56M | $169.45M | $205.21M | $210.69M | $237.92M |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | $37.03M | $56.39M | $24.79M | $24.96M | $36.58M |
| Capital expenditure | -$8.19M | -$10.15M | -$10.58M | -$10.24M | -$13.86M |
| Free cash flow | $25.82M | $44.50M | $14.21M | $14.71M | $22.72M |
| Dividends paid | $1.87M | $1.88M | $1.87M | - | $1.83M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CLB | $9.77 | -3.8% | 694.61K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |